SCHEMBL13114497

SCHEMBL13114497

O=C(O)c1cc(Br)cc2c1CCCO2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.53
▸ AKR1C3 P42330 2/20 0.40
▸ AKR1C2 P52895 2/20 0.40
▸ AKR1C1 Q04828 2/20 0.40
▸ AKR1C4 P17516 1/20 0.40
▸ HPGD P15428 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ MAPK10 P53779 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19123620 0.90 SMN1; SMN2 (0.47) SMN1; SMN2AKR1C3AKR1C2AKR1C1AKR1C4
SCHEMBL13315468 0.79 SMN1; SMN2 (0.58) SMN1; SMN2AKR1C3AKR1C2AKR1C1AKR1C4
SCHEMBL14390906 0.76 ALOX15 (0.38) SMN1; SMN2HPGDKMT2AMEN1MAPT
SCHEMBL6468002 0.75 KDM4E (0.42) SMN1; SMN2HPGDHSD17B10KDM4EGLA
SCHEMBL4640445 0.75 SMN1; SMN2 (0.49) SMN1; SMN2AKR1C3AKR1C2AKR1C1AKR1C4
SCHEMBL984633 0.73 SMN1; SMN2 (0.44) SMN1; SMN2HPGDHSD17B10KDM4EKMT2A
SCHEMBL19123318 0.73 AKR1C3 (0.44) SMN1; SMN2AKR1C3AKR1C2AKR1C1AKR1C4
SCHEMBL30995642 0.73 AKR1C3 (0.44) SMN1; SMN2AKR1C3AKR1C2AKR1C1AKR1C4
SCHEMBL11732758 0.73 AKR1C3 (0.44) SMN1; SMN2AKR1C3AKR1C2AKR1C1AKR1C4
SCHEMBL31204901 0.73 LMNA (0.35) SMN1; SMN2ALDH1A1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537091-B1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS HOFFMANN LA ROCHE (CH) 2010-10-06 — — EP disclosed
EP-1572203-B1 SUBSTITUTED 4-ALKOXYOXAZOL DERIVATIVES AS PPAR AGONISTS HOFFMANN LA ROCHE (CH) 2007-11-07 — — EP disclosed
Send feedback